The Rheumatologist: February 2021

okawa somchai / shutterstock.com

Case Report: A Lupus Patient with Abdominal Pain

February 16, 2021 • By Emily Purcell, MD, Colin Ligon, MD, MHS, & Chris T. Derk, MD, MS

Point-of-Care Testing for COVID-19

February 16, 2021 • By Philip Seo, MD, MHS

The Character of Rheumatology Has Changed Over the Past 50 Years

February 16, 2021 • By Bruce Rothschild, MD

Lost and found

The History of ACE Inhibitors in Scleroderma Renal Crisis

February 16, 2021 • By Ruth Jessen Hickman, MD

The ARP Revises Its Fundamentals of Rheumatology Course

February 16, 2021 • By Hiral Master, PT, PhD, MPH, Teresa J. Brady, PhD, Aileen Ledingham, PT, MS, PhD, & Carole Dodge, OT, CHT, on behalf of the ARP eLearning Subcommittee

The Effects of IL-17A Inhibitors on the Microbiota

February 16, 2021 • By Vanessa Caceres

Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

February 16, 2021 • By Elizabeth Hofheinz, MPH, MEd

The Unapproved-Drugs Initiative Is Coming to an End

February 16, 2021 • By Jason Melehani, MD, PhD

A New $1 Million Endowed Chair Honors Dr. Richard M. Silver

February 16, 2021 • By Catherine Bennett

Research Coordinators Offer a Lot to Clinical Rheumatology Research Teams

February 16, 2021 • By Donah Zack Crawford, MA, & Jeff Newcomb, BA

Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

February 16, 2021 • By William J. Scheuing, MD, Nitasha Kumar, MD, William Davis, MD, & Robert Quinet, MD

Study Finds Renal Arteriosclerosis Is Common in Lupus Nephritis Patients

February 16, 2021 • By Mary Beth Nierengarten

Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots

January 25, 2021 • By Mary Beth Nierengarten

Late-Breaking Abstract Session Spans the Realm of Drug-Related Research

January 25, 2021 • By Vanessa Caceres

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

January 25, 2021 • By Lara C. Pullen, PhD

Smart, Stem Cell-Based Implants May Revolutionize the Treatment of Arthritis

January 25, 2021 • By Lara C. Pullen, PhD

B Cell Depletion: The Latest Information on Disease Processes, Therapies

January 25, 2021 • By Lara C. Pullen, PhD

Tell a Convincing Story: Tips from the Experts on How to Secure Research Grants

January 22, 2021 • By Thomas R. Collins

ACR Convergence 2020

Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities

January 25, 2021 • By Mary Beth Nierengarten

The Psychosocial Toll of COVID-19

January 25, 2021 • By Thomas R. Collins

Case Report: Drug-Induced Lupus & ANCA-Associated Vasculitis Overlap

February 16, 2021 • By Mohammad A. Ursani, MD, RhMSUS, Ojas Naik, MD, Rohaan Khan & William F. Glass II, MD, PhD

Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients

February 16, 2021 • By Susan Bernstein

The ACR’s 2020 Advocacy Year in Review

February 16, 2021 • By Blair Solow, MD, & Zachary Wallace, MD, MSc

Reporting & Other Tips for the CARES Act Provider Relief Fund

February 16, 2021 • By Steven M. Harris, Esq.

Rheum After 5: Dr. Angus Worthing, the Singing Rheumatologist

February 16, 2021 • By Carol Patton

Risankizumab May Improve Symptoms of PsA

January 21, 2021 • By Michele B. Kaufman, PharmD, BCGP

Hydroxychloroquine Cardiotoxicity in RA Patients

January 5, 2021 • By Michele B. Kaufman, PharmD, BCGP

« Return to the Issue Archive